Skip to the guide
EXACT 41

Neurotransmission research / EDUCATIONAL GUIDE

Selank

Selank 10 mg box packaging mockup
Packaging mockup
10 mg€29.90

Research aims, observed effects
and the limits of the evidence.

Limited human and animal evidenceSources checked 6 September 2026

THE IDEA IN EVERYDAY TERMS

Anxiety and the signals between nerve cells

Selank is studied for possible anxiety-reducing effects. A simple way to frame the question is whether it changes nerve-cell signalling in a way that reduces anxiety symptoms. Rat experiments examined genes involved in GABA-related signalling; this is a clue about biology, not proof of exactly how it works in people.

Read the background ↗

Small comparative human study + rat research

What has actually been shown?

A study involving 60 people with anxiety-related disorders reported anxiety-reducing effects compared with phenazepam. That is a reason for further research, but a small comparative study cannot establish reliable results across anxiety conditions. The evidence reviewed here does not justify promises of instant calm, improved focus or a treatment free of side effects.

Read the evidence ↗

01 / OVERVIEW

What is Selank?

Selank is a synthetic peptide investigated in anxiety and neurotransmission research. [1]

02 / RESEARCH AIMS

Why it is studied.

A small comparative study examined anxiety symptoms in 60 patients. Separate rat experiments explored changes in genes involved in neurotransmission. [1]

03 / RESEARCH MAP

Following the research question.

Rat gene-expression work investigated GABA-related signalling. An observed gene-expression pattern does not establish one definitive mechanism in people. [3]

Selank research map: Synthetic peptide; GABA-related research; Limited clinical evidenceRESEARCH MAP / SELANK01Synthetic peptide02GABA-related research03Limited clinical evidence
Conceptual research map, not a molecular structure or a proven chain of clinical effects. [3]

04 / OBSERVED EFFECTS

What the evidence shows.

The comparative human report described anxiolytic effects, but its size and design limit broad conclusions. It is not equivalent to a large replicated placebo-controlled evidence base. [1]

Study context

Small comparative study

Key distinction

Rat gene-expression study

Uncertainty

Long-term questions

A selected-source overview, not a systematic review. Research findings are not verified effects of an independently supplied sample.

05 / SAFETY AND LIMITATIONS

Risks belong beside the findings.

FDA identifies important human safety gaps and potential immunogenicity concerns. [2]

Long-term safety and reliable effects across different anxiety conditions are not established by these studies.

06 / REFERENCES

Go to the source.

  1. Selank and phenazepam comparison ↗

    2014. Comparative study of 60 patients; limitations apply.

  2. FDA — Safety concerns for certain compounded substances ↗

    Regulatory safety assessment; route and formulation matter.

  3. Selank and GABA-related gene expression ↗

    Frontiers in Pharmacology, 2016. Rat study.